Mangalam Drugs and Organics Ltd.

Mangalam Drugs and Organics Ltd. (NSE/BSE: MANGALAM) is an Indian publicly listed company quoted on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The company operates in healthcare, a sector that combines regulated pricing with long-run demand growth from a rising domestic patient base. Its securities trade under ISIN INE584F01014. It is listed under the EQ series. As of the most recent update, Mangalam Drugs and Organics Ltd. carries an equity market capitalisation of approximately ₹46.17 Cr, which places it among the tracked constituents of the Healthcare sector on Indian exchanges. Detailed shareholding-pattern disclosures are published quarterly by Mangalam Drugs and Organics Ltd. via stock-exchange filings. For investors and researchers tracking healthcare listings, MANGALAM provides a window into how listed Indian capital is being allocated within the sector — by promoters, by foreign institutions, and by retail participants. This page consolidates Mangalam Drugs and Organics Ltd.'s core registration, listing and shareholding data into a single open record. Figures are refreshed weekly from the official NSE archives and BSE scrip master; the company's own filings remain the authoritative source for governance, financial and disclosure data.